Compare EXLS & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EXLS | BIRK |
|---|---|---|
| Founded | 1999 | 1774 |
| Country | United States | United Kingdom |
| Employees | 65000 | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.6B |
| IPO Year | 2004 | 2023 |
| Metric | EXLS | BIRK |
|---|---|---|
| Price | $35.30 | $31.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | $46.80 | ★ $61.43 |
| AVG Volume (30 Days) | 1.7M | ★ 2.1M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.27 | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.61 | $13.71 |
| Revenue Next Year | $10.55 | $14.30 |
| P/E Ratio | $82.00 | ★ $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.85 | $29.93 |
| 52 Week High | $44.32 | $50.73 |
| Indicator | EXLS | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 50.40 | 42.68 |
| Support Level | $34.33 | $31.33 |
| Resistance Level | $36.55 | $37.29 |
| Average True Range (ATR) | 0.85 | 1.06 |
| MACD | -0.31 | 0.20 |
| Stochastic Oscillator | 34.11 | 43.17 |
ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.